Teleflex price target lowered to $250 from $275 at Mizuho

Mizuho analyst Anthony Petrone lowered the firm’s price target on Teleflex (TFX) to $250 from $275 and keeps a Neutral rating on the shares following the “mixed” Q3 report. Although the near-term will likely remain pressured, the outlook for Urology with Pallette momentum is favorable, the analyst tells investors in a research note.